Timothy J. Scannell

Timothy J. Scannell was elected to our Board in February 2021. He recently retired after a 32 year career at Stryker where he last served as President and Chief Operating Officer from 2018 to 2021. Prior to this position, he served as Group President, responsible for the MedSurg and Neurotechnology businesses at Stryker from 2008-2018. Prior to the Group President role, Mr. Scannell served as President of Stryker Spine and Vice President & General Manager of Stryker Biotech. Mr. Scannell is a Director and Chair of the Board of Insulet Corporation and a Director of Masimo.